Amitriptyline Market Size Share Outlook and Opportunity Analysis 2019– 2027

1. AMITRIPTYLINE MARKET ANALYSIS INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND OPPORTUNITY ANALYSIS, 2020–2027 © Coherent market Insights. All Rights Reserved © Coherent market Insights. All Rights Reserved

2. REPORT DESCRIPTION Amitriptyline Market - Overview Global Amitriptyline Market, By Strength (10 mg tablets, 25 mg tablets, 50 mg tablets, 75 mg tablets, 100 mg tablets, and 150 mg tablets), By Indication (Depression, Nocturnal Enuresis, Migraine, Chronic Neuropathic Pain, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), is estimated to be valued at US$ 527.4 million in 2020 and is expected to exhibit a CAGR of 5.3% during the forecast period (2020- 2027), as highlighted in a new report published by Coherent Market Insights. The increasing R&D activities focused on evaluating the efficiency of amitriptyline in various therapeutic areas, is expected to drive the growth of the global amitriptyline market. For instance, in April 2016, Boston Medical Center initiated phase 2 clinical study to compare the effectiveness of amitriptyline versus placebo (inactive medication) in treating chronic laryngitis. The study is expected to complete in October 2022. Global AmitriptylineMarket – Impact of Coronavirus (COVID-19) Pandemic Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 100 countries across the globe with the World Health Organization declaring it a public health emergency. Browse Research Reports: https://www.coherentmarketinsights.com/market- insight/amitriptyline-market-4226 © Coherent market Insights. All Rights Reserved

3. REPORT DESCRIPTION COVID-19 has affected the economy in three main ways; by directly affecting production and demand, by creating disruptions in distribution channel, and by its financial impact on firms and financial markets. Due to nationwide lockdowns, several countries such as India, China, UAE, Saudi Arabia, and others are facing problems with regards to transportation of drugs from one place to another. The coronavirus (COVID-19) pandemic and resulting lockdowns in various countries across the globe have impacted the financial status of businesses in all sectors. The private healthcare sector has been impacted significantly by the pandemic. Healthcare providers were facing problems in investing additional manpower, equipment, consumables, and other resources to ensure safety in hospitals, provide treatment to patients with other diseases, and declining outpatient visits, etc. Furthermore, pharmaceutical companies are facing major challenges on various fronts due to the pandemic. The major challenges include disruption in supply of raw materials required for manufacturing drug formulations due to irregularities in transportation. Moreover, distributors of drug products are experiencing irregular demand from retailers. Browse 36 Market Data Tables and 37 Figures spread through 178 Pages and in-depth TOC on “Global Amitriptyline Market, By Strength (10 mg tablets, 25 mg tablets, 50 mg tablets, 75 mg tablets, 100 mg tablets, and 150 mg tablets) Request a Sample copy of this reports: https://www.coherentmarketinsights.com/insight/request-sample/4226 © Coherent market Insights. All Rights Reserved

4. REPORT DESCRIPTION The global amitriptyline market growth is expected to be driven by high prevalence of depression and prescriptions of antidepressants. For instance, according to data published by the American Psychological Association in 2017, there was a 64% increase in the percentage of people using antidepressants between 1999 and 2014 in the U.S. Key Takeaways of the Global Amitriptyline Market: The global amitriptyline market is expected to exhibit a CAGR of 5.3% during the forecast period owing to the increasing prevalence of depression among the population, which may facilitate demand for amitriptyline. Moreover, research institutes are also engaged in conducting clinical trials which is contributing to growth of the market. For instance, in September 2020, the University of California, Davis commenced a clinical trial to assess the physiological and behavioral mechanisms associated with amitriptyline in adult patients with functional GERD-related symptoms. The study estimated to complete in December 2021. Key players operating in the global amitriptyline market are Accord Healthcare Inc., Mylan Pharmaceuticals Inc., Sandoz Inc., Sun Pharmaceutical Industries Inc., Vintage Pharmaceuticals Inc., Zydus Pharmaceuticals USA Inc., Watson laboratories Inc., and Torrent Pharmaceuticals Ltd. Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/4226 © Coherent market Insights. All Rights Reserved

5. ABOUT COHERENT MARKET INSIGHTS ABOUT US Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele. SERVICES CUSTOMIZED RESEARCH INDUSTRY ANALYSIS SYNDICATED RESEARCH COUNTRY SPECIFIC STUDIES MARKET INTELLIGENCE SERVICES CONSULT STUDIES © Coherent market Insights. All Rights Reserved

6. ABOUT CMI SECTOR COVERAGE BIOTECHNOLOGY CLINICAL DIAGNOSTIC HEALTHCARE IT MEDICAL DEVICES MEDICAL IMAGING PHARMACEUTICAL OUR CLIENTS  Global Leading Equipment and System Manufacturers  Marketing Consultancies and the Advertising Industry  Component Providers and System Integrators  Private and Government organization  Distributors, Retailors and Value Added Resellers  Outsourcing Companies  Healthcare IT Solutions Developers  Universities and Business Schools. © Coherent market Insights. All Rights Reserved

7. KEY STATS RESEARCH SOLUTIONS 100+ GLOBAL REPORTS FEASIBILITY STUDIES Insights Published Per Year CUSTOMIZED SOLUTIONS 150+ COUNTRY ANALYSIS Consulting Projects Till Date CONSULT PROJECTS SURVEY RESEARCH 125+ EXCEL FORECAST DATABASE Clients Worldwide Per Year COMPETITIVE ASSESSMENT TECHNOLOGY SNIPPETS 110+ Analysts and Contract Consultants Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein. © Coherent market Insights. All Rights Reserved

8. THANK YOU To know more about us, visit our website: www.coherentmarketinsights.com For sales queries or new topics email us on: sales@coherentmarketinsights.com For other queries contact: Mr. Shah (Manager - Business Development) Coherent Market Insights sales@coherentmarketinsights.com +1-206-701-6702 © Coherent market Insights. All Rights Reserved